194 related articles for article (PubMed ID: 32996835)
1. Treatment of feline gastrointestinal intermediate- or large-cell lymphoma with lomustine chemotherapy and 8 Gy abdominal cavity radiation therapy.
Gieger TL; Seiler GS; Nolan MW
J Feline Med Surg; 2021 Jun; 23(6):469-476. PubMed ID: 32996835
[TBL] [Abstract][Full Text] [Related]
2. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
Rau SE; Burgess KE
Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
[TBL] [Abstract][Full Text] [Related]
3. Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Smallwood K; Harper A; Blackwood L
J Feline Med Surg; 2021 Aug; 23(8):722-729. PubMed ID: 33176543
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
Dutelle AL; Bulman-Fleming JC; Lewis CA; Rosenberg MP
J Feline Med Surg; 2012 Oct; 14(10):694-700. PubMed ID: 22577051
[TBL] [Abstract][Full Text] [Related]
5. LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus.
Horta RS; Souza LM; Sena BV; Almeida IO; Jaretta TA; Pimenta MM; Reche Júnior A
J Feline Med Surg; 2021 Feb; 23(2):86-97. PubMed ID: 32684120
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy followed by abdominal cavity irradiation for feline lymphoblastic lymphoma.
Williams LE; Pruitt AF; Thrall DE
Vet Radiol Ultrasound; 2010; 51(6):681-7. PubMed ID: 21158247
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy in feline lymphoma: treatment outcome, tolerability, and duration in 23 cats.
Simon D; Eberle N; Laacke-Singer L; Nolte I
J Vet Intern Med; 2008; 22(2):394-400. PubMed ID: 18312554
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
Saba CF; Thamm DH; Vail DM
J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
[TBL] [Abstract][Full Text] [Related]
9. Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
Rassnick KM; Williams LE; Kristal O; Al-Sarraf R; Baez JL; Zwahlen CH; Dank G
J Am Vet Med Assoc; 2008 Apr; 232(8):1200-5. PubMed ID: 18412534
[TBL] [Abstract][Full Text] [Related]
10. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma.
Martin OA; Price J
J Feline Med Surg; 2018 Oct; 20(10):934-939. PubMed ID: 29065803
[TBL] [Abstract][Full Text] [Related]
11. Retrospective evaluation of nimustine use in the treatment of feline lymphoma.
Sakai K; Hatoya S; Furuya M; Nabetani T; Kanegi R; Shimamura S; Tani H; Shimada T
Vet Med Sci; 2022 Jan; 8(1):3-8. PubMed ID: 34599792
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a multiagent chemotherapy protocol combining vincristine, cyclophosphamide, mitoxantrone and prednisolone (CMOP) for treatment of feline intermediate-large cell lymphoma.
Webster J; McNaught KA; Morris JS
J Feline Med Surg; 2024 Apr; 26(4):1098612X241234614. PubMed ID: 38647264
[TBL] [Abstract][Full Text] [Related]
13. Treatment of feline intermediate to high-grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017-2021).
Moore AS; Frimberger AE
Vet Comp Oncol; 2024 Mar; 22(1):106-114. PubMed ID: 38152842
[TBL] [Abstract][Full Text] [Related]
14. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
15. Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen.
Krupa A; de Vos J; Van Eetvelde L; Teske E
J Feline Med Surg; 2022 Aug; 24(8):e203-e213. PubMed ID: 35748790
[TBL] [Abstract][Full Text] [Related]
16. A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
Elliott J; Finotello R
Vet Comp Oncol; 2018 Mar; 16(1):E144-E151. PubMed ID: 29044884
[TBL] [Abstract][Full Text] [Related]
17. Feline high-grade and large granular lymphocyte alimentary lymphomas treated with COP- or CHOP-based chemotherapy: A multi-centric retrospective study of 57 cases.
Bernardo Marques G; Ponce F; Beaudu-Lange C; Béguin J; Boissy L; Chavalle T; Denoeux P; Diop N; Ferro L; Floch F; Lajoinie M; Sayag D; Barrett LE; Chamel G
Vet Comp Oncol; 2024 Jun; 22(2):186-197. PubMed ID: 38356238
[TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.
Rassnick KM; Gieger TL; Williams LE; Ruslander DM; Northrup NC; Kristal O; Myers NC; Moore AS
J Vet Intern Med; 2001; 15(3):196-9. PubMed ID: 11380027
[TBL] [Abstract][Full Text] [Related]
19. Prospective clinical trial to compare vincristine and vinblastine in a COP-based protocol for lymphoma in cats.
Krick EL; Cohen RB; Gregor TP; Salah PC; Sorenmo KU
J Vet Intern Med; 2013; 27(1):134-40. PubMed ID: 23157371
[TBL] [Abstract][Full Text] [Related]
20. Combined Hypofractionated Radiotherapy and Chemotherapy Versus Hypofractionated Radiotherapy Alone for Cats with Localized Sinonasal Lymphoma.
Goto S; Iwasaki R; Sakai H; Mori T
J Am Anim Hosp Assoc; 2022 Sep; 58(5):254-261. PubMed ID: 36049238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
